Group One Trading
CRBU icon

Group One Trading’s Caribou Biosciences CRBU Stock Holding History

Group One Trading’s Portfolio CRBU Stock Details CRBU Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$9.53K Buy
+5,416
New +$10.7K ﹤0.01% 6424
2025
Q4 		– Sell
-6,084
Closed -$12.8K – 8266
2025
Q3 		$14.2K Sell
6,084
-19,831
-77% -$37.4K ﹤0.01% 6943
2025
Q2 		$32.7K Buy
25,915
+2,600
+11% +$2.56K ﹤0.01% 5913
2025
Q1 		$21.3K Buy
+23,315
New +$30.3K ﹤0.01% 5780
2024
Q4 		– Sell
-6,726
Closed -$13.5K – 7372
2024
Q3 		$13.2K Buy
6,726
+3,557
+112% +$7.28K ﹤0.01% 5467
2024
Q2 		$5.2K Buy
+3,169
New +$10.1K ﹤0.01% 5933
2023
Q4 		– Sell
-745
Closed -$3.68K – 7496
2023
Q3 		$3.56K Sell
745
-155
-17% -$962 ﹤0.01% 6846
2023
Q2 		$3.83K Hold
900
– – ﹤0.01% 6833
2023
Q1 		$4.78K Sell
900
-1,400
-61% -$8.72K ﹤0.01% 6295
2022
Q4 		$14.4K Sell
2,300
-600
-21% -$5.34K ﹤0.01% 5822
2022
Q3 		$31K Buy
2,900
+200
+7% +$1.86K ﹤0.01% 5780
2022
Q2 		$15K Buy
+2,700
New +$20.6K ﹤0.01% 6497

Other funds holding CRBU

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
P
Pfizer New York $170M AUM 191.09% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Mackenzie Financial
Mackenzie Financial Toronto Ontario, Ontario, Canada $100B AUM 36.93% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
KCM
Kynam Capital Management Princeton, New Jersey $1.81B AUM 192.15% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Group One Trading's CRBU Position: Q2 2026 in Review

Group One Trading opened a new position in Caribou Biosciences (CRBU) in Q2 2026: 5,416 shares worth $9.53K. The stake represents ﹤0.01% of the portfolio and ranks #6424 among its holdings. This is a return to the name: Group One Trading previously reported a position in CRBU as recently as Q3 2025.

Group One Trading first reported a position in CRBU in Q2 2022 and has held it in 12 quarters since. The position peaked at $32.7K in Q2 2025. 137 funds tracked by Wall St. Rank hold CRBU as of Q2 2026.

  • Group One Trading held 5,416 shares of Caribou Biosciences worth $9.53K as of Q2 2026.
  • Caribou Biosciences was a new Group One Trading position in Q2 2026.
  • Caribou Biosciences made up ﹤0.01% of Group One Trading's portfolio in Q2 2026, its #6424 holding.
  • Group One Trading first reported a position in Caribou Biosciences in Q2 2022 and has held it in 12 quarters since.
  • Group One Trading's Caribou Biosciences position peaked at $32.7K in Q2 2025.
  • 137 funds tracked by Wall St. Rank held Caribou Biosciences as of Q2 2026.

Based on Group One Trading's 13F filing for Q2 2026, filed 14 Aug 2026.